Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.

Go back to Resources

Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.

Go back to Resources

Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.

Authors:

Secondary:

PMID:

DOI:

Abstract:

Go back to Resources

Structural and Volumetric Brain MRI Findings in Mild Traumatic Brain Injury.

Go back to Resources

Structural and Volumetric Brain MRI Findings in Mild Traumatic Brain Injury.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.

Go back to Resources

Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.

Go back to Resources

Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.

Go back to Resources

Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Population pharmacokinetics of olanzapine in children.

Go back to Resources

Population pharmacokinetics of olanzapine in children.

Authors:

Secondary:

PMID:

DOI:

Abstract:

Go back to Resources

Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.

Go back to Resources

Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.

Authors:

Secondary:

Volume:

Pagination:

PMID:

DOI:

Abstract:

Go back to Resources

Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.

Go back to Resources

Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.

Authors:

Secondary:

Volume:

Pagination:

PMID:

DOI:

Abstract:

Go back to Resources

Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Procedures by Prehospital Providers.

Go back to Resources

Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Procedures by Prehospital Providers.

Authors:

Secondary:

Pagination:

PMID:

DOI:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 98
  • Page 99
  • Page 100
  • Page 101
  • Current page 102
  • Page 103
  • Page 104
  • Page 105
  • Page 106
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification